产品中心 药物靶点和Fc受体 小分子药物靶点蛋白

所有图片(1/3)

NEK7 GST Tag Protein, Human

NimA-related protein kinase 7,Never in mitosis A-related kinase 7

价格 3,080.00 供应商现货 : 3-5个工作日
货号 UA085018
规格
数量
收藏 分享

产品介绍 评论(0)

产品规格
  • 物种

    Human
  • 分子别名

    NimA-related protein kinase 7, Never in mitosis A-related kinase 7
  • Accession

    Q8TDX7
  • 表达序列

    Met1-Ser302 with GST Tag at the N-Terminus

  • 表达宿主

    E.coli
  • 分子量

    55-70kDa (Reducing)

  • 纯度

    >90% by SDS-PAGE & > 90% by HPLC
  • 活性

    The specific activity of NEK7 was determined to be >6.0 nmol /min/mg as per activity assay protocol.
  • 标记

    Unconjugated
  • 标签

    GST Tag
  • 性状

    Liquid
  • 缓冲体系

    50mM Tris, 150mM NaCl, pH7.5, 1mM DTT, 10%Glycerol

  • 储存条件

    Stable for 12 months upon stored at -80℃ from the date of receipt. And avoid repeated freeze-thaws cycles.

  • 文献引用

    1. Shi, H., et al. (2016). NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7. Nature, 540(7631), 440-445.
    2. He, Y., Zeng, M.Y., Yang, D., Motro, B., & Núñez, G. (2016). NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature, 540(7631), 123-127.
    3. Kim, S., Lee, K., & Rhee, K. (2007). NEK7 is a centrosomal kinase critical for microtubule nucleation. Biochemical and Biophysical Research Communications, 360(1), 56-62.

背景介绍
  • NEK7 (NIMA-related kinase 7) is a serine/threonine kinase belonging to the NEK family. It plays a crucial and specific role in regulating cell cycle progression, particularly in mitotic entry and spindle assembly. Structurally distinct from other NEK kinases, NEK7 contains an N-terminal catalytic kinase domain and a C-terminal regulatory domain. Its activity is tightly controlled by cell cycle-dependent phosphorylation and its interaction with NEK9. The NEK9/NEK6/NEK7 cascade is a key pathway for mitotic centrosome separation and spindle formation.
操作步骤
  • 实验方法

    实验原理:使用ADP-Glo™激酶检测试剂盒进行NEK7活性测定,该试剂盒用于定量检测NEK7反应产生的ADP量。具体步骤如下:首先加入ADP-Glo™试剂以终止激酶反应并消耗剩余ATP;随后加入激酶检测试剂,将ADP转化为ATP,并通过荧光素酶/荧光素反应体系检测新合成的ATP

    实验材料

    1. Kinase assay buffer(5X): 200 mM Tris-HCl, pH 7.4, 100 mM MgCl2 and 0.5 mg/mL BSA, 250 μM DTT

    2. Kinase assay buffer(1X): 40 mM Tris-HCl, pH 7.4, 20 mM MgCl2, 0.1 mg/mL BSA, 50 μM DTT

    3. NEK7 GST Tag Protein, Human

    4. ADP-Glo Kinase Assay (Promega, Catalog # V6930)

    5. 底物: Casein substrate (Sinobiological, Catalog # C03-54N)

    6. Solid white multi-well plate (384-well plate) (Corning, Catalog #3572)

    7. 读板器(PerkinElmer

    实验步骤

    1. 配制底物/ATP混合液,操作如下(以25 μM为例):

    Sample Name

    Amount (μL)

    10 mM ATP Solution

    1

    Kinase Assay Buffer III (5x)

    79

    Substrate at 1 mg/mL

    80

    1. 用激酶检测缓冲液(1x)将NEK7稀释至15 µg/mL, 7.5 µg/mL3.75 µg/mL,并在 384 孔板的每个孔中加入3 µL

    2. 通过向每个孔中加入2 µL微升步骤1中配制的检测系统来启动反应。设置一个仅加入 3 µL激酶检测缓冲液(1x)的检测系统作为空白对照。反应总体积为5 µL。将反应在室温(22–25)下孵育40分钟。

    3. 向反应完成的体系中加入5 µL ADP-Glo Reagent,短暂混匀后在室温(22–25)下孵育 40分钟。

    4. 加入10 µL Detection Reagent,将板在室温(22–25)下孵育30分钟。

    5. 分别使用终点模式读取化学发光信号。

    6. 计算比活性。

    标准曲线

    1. 在激酶检测缓冲液()中将ATPADP稀释至25 μM

    2. 按下表所示,混合25 μM ATP25 μM ADP,配制ATP+ADP混合液,并在384孔板的每个孔中加入5 μL

    Well Number

    1

    2

    3

    4

    5

    6

    7

    8

    9

    10

    11

    12

    25μM ADP (μL)

    100

    80

    60

    40

    20

    10

    5

    4

    3

    2

    1

    0

    25μM ATP (μL)

    0

    20

    40

    60

    80

    90

    95

    96

    97

    98

    99

    100

    1. 向反应完成的孔中加入5 μL ADP-Glo试剂,短暂混匀,在室温(22-25°C)下孵育40分钟。
    2. 加入10 μL检测试剂,在室温(22-25°C)下孵育30分钟。
    3. 在终点模式下分别读取化学发光信号。
    4. 检测光信号并建立转换曲线。

    Specific Activity (pmol/min/μg) =

    ATP (pmol)-Blank

    Incubation time(min) ×amount of enzyme (μg)


  • 生物活性

    • NEK7 GST Tag Protein, Human: The specific activity of NEK7 was determined to be >6.0 nmol/min/mg as per activity assay protocol.

  • 电泳

    • 2μg (R: reducing condition, N: non-reducing condition).

  • 体积排阻色谱(SEC-HPLC)

    • The purity of NEK7 GST Tag Protein, Human is more than 95% determined by SEC-HPLC.

评论(0)